French Maritime Pine Bark Extract.
Research-backed herb with potential health benefits. Boosts blood flow by increasing nitric oxide, protects skin collagen, and acts as a strong antioxidant. Think better circulation from head to toe.
Reviewed March 2026
- Category
- Herb
What French Maritime Pine Bark Extract is, and what it does.
- Does it work
- Suits people focused on circulation, tired legs or skin, and people who already build a formula around flavanols. If you take a blood thinner, talk to your clinician first.
- How much to take
- 100-150mg daily. You can take it all at once or split it into two doses with food to be safe.
- Time to feel it
- About two weeks of daily use.
- The first dose
- Nothing. Don't expect any immediate changes. This needs time to build up and work.
- With regular use
- After 4-8 weeks, you might see improvements in skin hydration, reduced leg swelling, and maybe a little cognitive boost. The benefits are cumulative.
- How well tolerated
- Well tolerated for most. The main watch-out is with blood thinners like warfarin. Check with your doctor. Some mild gut upset is possible initially.
- How it feels
- Like nothing, at first. It's not a stimulant. The effect is a gradual improvement in how your body functions, not a 'feeling'.
- The overlooked benefit
- Most of what circulates isn't the procyanidins at all. Gut bacteria break the larger oligomers into phenyl-gamma-valerolactones, and those metabolites dominate your blood profile.
50 to 150mg a day is where French Maritime Pine Bark Extract works.
Source: Rohdewald, Int J Clin Pharmacol Ther, 2002; Pycnogenol studies
A double blind randomised placebo controlled study gave 180 mg per day of the standardised French maritime pine bark extract Pycnogenol, or placebo, to 16 healthy young men, 8 per arm, for 2 weeks. Forearm blood flow response to acetylcholine, an endothelium dependent vasodilator, rose from 13.1 to 18.5 mL per minute per 100 mL of tissue after the extract and did not change on placebo. Response to sodium nitroprusside, which does not depend on the endothelium, was unchanged, and a nitric oxide synthase inhibitor abolished the effect. Resting forearm and systemic haemodynamics were unchanged in both arms. This is one small trial measuring a vascular marker rather than a symptom.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
French Maritime Pine Bark Extract is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- endothelial function and blood flowMeta-analysis
- comfort in tired, heavy legsRandomised trial
- skin hydration and elasticityRandomised trial
- blood pressure already in the normal rangeMeta-analysis
- oxidative stress markersRandomised trial
- attention and cognitive performanceRandomised trial
- exercise performance and recoveryRandomised trial
- seasonal nasal and eye comfortRandomised trial
Questions people ask about French Maritime Pine Bark Extract.
- Is Pycnogenol the same thing?
- Yes. Pycnogenol is just the main, heavily researched brand name for this extract. It's the one most studies use.
- What's it best for?
- Blood flow and skin health. It's a top-tier antioxidant for those two areas.
- Can I take it with other supplements?
- Yes, generally plays well with others. Just be cautious if you're also taking high-dose fish oil or ginkgo, as they can also affect blood clotting.
- Will it help my varicose veins?
- It can help with the symptoms, like swelling and leg heaviness. The evidence for that is pretty good.
- Is it a stimulant?
- Nope. No caffeine, no buzz. It works on your circulatory system, not your central nervous system in that way.
- Is it better than Vitamin C?
- It's different. It actually helps recycle Vitamin C in your body, making it more effective. They work well together.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
L-arginine is the substrate the enzyme nitric oxide synthase uses to make nitric oxide, and pine bark procyanidins stimulate that same enzyme in the vessel lining. Feeding the enzyme more substrate alongside an extract that activates it supports the body's normal nitric oxide production, which helps relax blood vessel walls and supports healthy blood flow.
In the watery part of the cell, pine bark procyanidins hand an electron back to spent vitamin C and regenerate it, and vitamin C returns the favor by restoring the oxidized procyanidins. This mutual recycling lets both keep neutralizing free radicals for longer than either does alone.
Vitamin E is the main antioxidant protecting the fatty cell membranes, while pine bark procyanidins act in the surrounding water phase, so the pair guards two different compartments. The procyanidin and vitamin C system also regenerates the vitamin C that restores oxidized vitamin E, helping the vitamin E pool stay in its active form.
Pine bark procyanidins raise endothelial nitric oxide synthase activity, and that enzyme needs arginine as its substrate. Citrulline is the most reliable way to keep plasma arginine up because it escapes gut arginase.
Ubiquinol regenerates oxidised tocopherol inside membranes, and pine bark procyanidins work on the aqueous side of the same network. Together they cover both compartments of the recycling chain.
Lipoic acid restores ascorbate and glutathione, which in turn can return oxidised procyanidins to their active form. That places the two in the same regeneration relay rather than in parallel.
Both extracts are dominated by oligomeric proanthocyanidins acting on capillary integrity and nitric oxide handling. Because the actives overlap, combining them mainly adds to a shared dose rather than bringing a second mechanism.
Procyanidin radicals formed during antioxidant work are reduced back by cellular thiols. Glutathione is the largest of those pools, so its status affects how long the extract keeps cycling.
Proanthocyanidins bind collagen and elastin fibres and slow the elastase and collagenase activity that breaks them down. Collagen peptides supply the amino acid pattern for new fibres while the extract slows loss of existing ones.
Proanthocyanidins bind ferric iron through their catechol groups and form complexes the intestine does not absorb. Taken in the same window they lower non-heme iron uptake noticeably, so separating the doses is the usual answer.
The same phenolic hydroxyl groups that bind iron also complex zinc in the gut lumen. Mineral and high-polyphenol doses are better spaced rather than taken in one serving.
Pine bark procyanidins reduce platelet aggregation, and omega-3 fatty acids shift thromboxane production the same way. The combined effect on normal clotting is additive and matters around surgery or with anticoagulant medicine.
Ginkgolides antagonise platelet activating factor while procyanidins act on platelet reactivity by a separate route. Two brakes on the same process stack.
Dietary nitrate raises nitric oxide through the nitrate to nitrite to NO reduction route, while pine bark procyanidins act on the separate endothelial nitric oxide synthase arm. The review that groups these sources together found the polyphenol category less consistently supported than nitrate for endurance measures. Combining them addresses the same signalling molecule by two independent routes.
Both are polyphenols acting on endothelial nitric oxide handling and on NF-kB driven inflammatory signalling in cell work. They compete to some degree for the same UGT and SULT conjugation capacity, which changes the plasma balance of parent compound versus conjugate. Read the pairing as mechanistic; no combination trial of the two is cited here.
Pine bark procyanidins and curcuminoids both dampen NF-kB dependent transcription of inflammatory mediators in laboratory systems, and both have poor intrinsic oral bioavailability with heavy first-pass conjugation. Their gut microbial metabolites differ, so the pairing broadens the metabolite pool rather than simply doubling a dose. The evidence is marker-level and preclinical.
Astaxanthin sits within the lipid bilayer and spans it, while procyanidins and their valerolactone metabolites act in the aqueous phase. Pairing them covers oxidation in both compartments of the same membrane. Everything measured here is an oxidation marker, not a clinical endpoint.
Procyanidins bind and inhibit hyaluronidase and several matrix metalloproteinases in vitro, which slows the breakdown of the glycosaminoglycan matrix, while supplemental hyaluronic acid supplies substrate to that matrix. The pair shows up in skin and joint comfort formulas for that reason. The mechanism is enzymatic and in vitro.
Lutein accumulates in the macular pigment while pine bark procyanidins are studied for capillary and endothelial measures, so the two address different parts of the same tissue. Blends pair them on that division of labour. The grounding is mechanistic and conventional rather than a combination trial.
Garlic organosulfur compounds and pine bark procyanidins have each been reported to reduce platelet aggregation in laboratory and human marker studies. Stacking two agents that act on the same measure is worth flagging to anyone already on antiplatelet or anticoagulant medication, who should raise it with their prescriber. This is a caution about an additive direction, not a benefit claim.
Gingerols inhibit thromboxane-mediated platelet aggregation in vitro, and pine bark procyanidins act on the same measure by a different route. The combination pushes the same marker in the same direction. Flagged as an additive interaction to be aware of rather than as a reason to combine them.
Nattokinase has fibrinolytic activity in laboratory assays and pine bark procyanidins act on platelet aggregation, so both nudge haemostatic measures the same way. Anyone on anticoagulant therapy should have this pairing reviewed by their prescriber. The interaction is directional and mechanistic.
Condensed tannins and procyanidins bind copper and other transition metals through their catechol and galloyl groups, forming complexes that are less absorbable. Taking a high-tannin extract in the same dose window as a trace mineral lowers the free ion available at the brush border. Spacing them apart is the usual formulation answer.
Procyanidin oligomers bind proline-rich proteins tightly, which is the same chemistry that produces astringency in red wine and tea. In a protein-rich shake a portion of the extract is bound to protein rather than free in solution. The bound fraction is not destroyed but it changes what the analytical assay and the early gut see.
Procyanidin oligomers above the dimer are barely absorbed intact; the colonic microbiota cleaves them to phenyl-gamma-valerolactones and smaller phenolic acids, which are what actually circulate. The composition of that microbiota therefore sets an individual's metabolite exposure from the same dose. Read this as a bioavailability mechanism, not a claimed benefit of the pair.
Nothing specific on file for French Maritime Pine Bark Extract. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What French Maritime Pine Bark Extract actually does.
French maritime pine bark extract is defined by its procyanidin content: oligomers of catechin and epicatechin linked mainly through C4 to C8 bonds, together with monomeric flavanols, taxifolin and simple phenolic acids such as caffeic and ferulic acid.
Procyanidin absorption falls sharply with chain length; monomers and dimers cross the enterocyte, while larger oligomers pass to the colon where microbial ring fission yields phenyl-gamma-valerolactones that dominate the circulating metabolite profile.
As condensed tannins, the oligomers bind proteins and chelate divalent metal ions, which explains both the astringent mouthfeel of the extract and its capacity to reduce mineral solubility in the same dose window.
Flavanols from this extract increase endothelial nitric oxide synthase activity in vessel preparations, and nitric oxide is the mediator of normal vasodilation, which is the mechanistic basis behind its use in circulation-focused formulas.
Where French Maritime Pine Bark Extract comes from.
It is made from the bark of maritime pine trees grown for timber in south-west France. The bark is washed, dried, milled and extracted with water and alcohol, then filtered, concentrated and dried into a powder tested for its procyanidin content.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Bark of the maritime pine, taken as a by-product of managed timber forestry in south-western France; the bark is a residue of a wood harvest rather than a separately grown crop.
Washed and dried bark is milled and extracted with water and ethanol, which pulls the flavanol monomers, procyanidin oligomers and phenolic acids away from the lignin and cellulose.
Insoluble bark solids are filtered off and the solvent is stripped under reduced pressure to leave an aqueous concentrate.
The concentrate is assayed for procyanidin content by a declared method and adjusted to the supplier's specification range.
The standardised concentrate is spray dried, alone or onto a carrier, to a reddish-brown powder for capsules and tablets.
The forms it comes in.
The essence, in one line each.
- Pooling 27 randomised trials in 1,685 adults, pine bark extract lowered fasting blood sugar by about 6.25 mg/dL, HbA1c by 0.32 percent, body weight by 1.37 kg and LDL cholesterol by about 5 mg/dL, with no change detected in triglycerides, total cholesterol or BMI.Meta-analysis. Mohammadi et al., 2025 (BMC Complementary Medicine and Therapies). PMID 39987124 ↗
- An earlier pooling of 7 double-blind placebo-controlled trials in 626 participants did not detect any change in systolic or diastolic blood pressure with pine bark extract, so the blood pressure evidence is not consistent across reviews.Meta-analysis. Fogacci et al., 2019 (Angiology). PMID 31763928 ↗
- Across 3 pooled trials in long-haul air passengers, pine bark extract lowered leg swelling scores compared with control, though the trials varied widely from one another.Meta-analysis. Chan et al., 2021 (Nutrients). PMID 33809656 ↗
- Reviewing 27 randomised trials in 1,641 participants across 10 different uses, the authors rated nearly all of the evidence very low certainty and said no definitive conclusion about pine bark extract is possible yet.Systematic review. Robertson et al., 2020 (Cochrane Database of Systematic Reviews). PMID 32990945 ↗
- Pooling randomised trials of pine bark extract, the analysis did not detect a clear effect on plasma lipid levels, which is a failure to find a difference rather than evidence that none exists.Meta-analysis. Sahebkar, 2014 (Journal of cardiovascular pharmacology and therapeutics). PMID 24346156 ↗
- In outdoor workers in a Chinese city, oral pine bark extract over several weeks was followed by improvements in measured skin parameters such as hydration and pigmentation compared with placebo.Randomised trial. Zhao et al., 2021 (Skin pharmacology and physiology). PMID 33789311 ↗
- In postmenopausal women, an oligomeric pine bark extract changed circulating bone remodelling markers compared with placebo over the supplementation period; these are markers, not measured bone outcomes.Randomised trial. Panahande et al., 2019 (Phytotherapy research). PMID 30907034 ↗
- In postmenopausal women with lower bone density, an oligomeric pine bark extract was followed by lower oxidative stress markers and higher antioxidant capacity than placebo.Randomised trial. Majidi et al., 2021 (Phytomedicine). PMID 33250314 ↗
- French maritime pine bark extract supplementation was assessed against inflammatory and nutritional markers plus clinical status scores in the enrolled hospitalised adults; the reported endpoints are circulating markers and scores rather than long-term outcomes.Randomised trial. Malekahmadi M et al., 2021 (Phytotherapy Research). PMID 34382717 ↗
- Supplementation was evaluated against metabolic markers and serum vascular cell adhesion molecule concentrations; a change in an adhesion-molecule marker is a marker change, not a demonstrated outcome.Randomised trial. Navval-Esfahlan E et al., 2021 (Complementary Therapies in Medicine). PMID 33610726 ↗
- A published protocol setting out the planned assessment of inflammatory biomarkers under Pycnogenol supplementation; it describes design and endpoints and reports no results.Randomised trial. Malekahmadi M et al., 2020 (Trials). PMID 32046747 ↗
- In an experimental animal model of lung tissue injury, French maritime pine bark extract shifted inflammatory, oxidative and apoptotic pathway markers relative to untreated animals.Animal study. Ulas N et al., 2025 (Current Issues in Molecular Biology). PMID 41020892 ↗
- Across nitrate, polyphenol, L-arginine and L-citrulline sources, dietary nitrate had the most consistent support for endurance performance measures while the polyphenol category, which includes pine bark extract, was less consistent.Systematic review. d'Unienville NMA et al., 2021 (Journal of the International Society of Sports Nutrition). PMID 34965876 ↗
These are the studies our verdict leans on, chosen from the 448 we read for French Maritime Pine Bark Extract. The full linked list is below.
The studies, linked.
1 source behind our French Maritime Pine Bark Extract verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEvaluation the Effects of French Maritime Pine Bark Extract Supplementation on the Inflammatory Biomarkers, Nutritional and Clinical Status in Traumatic Brain Injury Patients, in Intensive Care Unit; A Randomized Clinical TrialClinicalTrials.gov ↗PHASE1 · 67 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.